Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the FDA revisits its decision to remove it.

New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

Have you finally decided to explore treatment plans for weight loss or erectile dysfunction? Are you finding that ...

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

Blockbuster diabetes and weight loss drugs, known as GLP-1 treatments, could help reduced the rate of overdoses and ...

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...

The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Eli ...

Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...

Authorities said Snyder's children, 4-year-old Brinley and 8-year-old Conner, were found hanging by a cable dog lead in September 2019, which Snyder later admitted to buying. The second suspect ...

Israelis Were Surprised to Discover Sinwar’s Body After Shooting Stopped The soldiers who killed Yahya Sinwar, a major target of Israel’s military campaign in Gaza, had not expected to run ...